BioCorRx Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 0.048272 million compared to USD 0.122621 million a year ago. Net loss was USD 5.21 million compared to USD 3.47 million a year ago.

Basic loss per share from continuing operations was USD 0.81 compared to USD 0.65 a year ago.